Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now
Stopped The study sponsor requested the study be terminated as the existing study design did not meet their needs.
Conditions
- Non-Small-Cell Lung Cancer
Sponsor
AstraZeneca